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IgG4-related systemic disease (IgG4-RSD) is an emerging autoimmune disorder that may affect several or-
gans, with signs of organ fibrosis, storiform masses for hystopathological plasmacellular infiltration and plas-
matic elevation of IgG4. This clinical condition frequently occurs in the sixth decade and may be considered 
an autoimmunity of the elderly; the disease may have a smouldering course with frequent misdiagnosis for the 
co-occurrence of comorbidity and clinical complexity.
The present case report describes the clinical case of an 81 years old woman admitted to the geriatric ward 
for remittent fever and functional decline. The past clinical history reported an isolated CT scan suggestive 
of retroperitoneal fibrosis of unknown origin with and a drug regimen that included chronic corticosteroids 
(prednisone 5 mg oad). The in hospital diagnostic workout demonstrated the presence of a thoracic aneurysm.
Several possible diagnoses among inflammatory, autoimmune (connective tissue disease, vasculitis, sarcoid-
osis, amyloidosis), infectious (mycotic) or neoplastic conditions were ruled out, as well as any drug association 
with higher risk of retroperitoneal fibrosis.
Thus, the clinical hypothesis of an IgG4 chronic periaortitis was formulated due to the co-occurrence of all 
the three major components: the presence of a retroperitoneal fibrosis, IgG4 related abdominal aortitis and 
peryaneurysmal fibrosis. Patient’s comorbidity did not allow performing the histological analysis. The present 
clinical case is original and adds knowledge to the 76 cases of thoracic aortitis due to IgG4 systemic disease 
out of the 3482 cases of disease reported so far. Further clinical investigation is needed to provide a homoge-
neous diagnostic workout for tailored early therapeutic intervention on the single geriatric patient. Moreover, a 
growing awareness of the disease is needed, especially in geriatrics, to providing a better standard of care and 
to improving the disease clinical knowledge and management. 
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IntroductIon
IgG4-related systemic disease (IgG4-RSD) is a sub 
acute autoimmune systemic disorder, characterized by 
the lymphoplasmatic infiltration of different organs and 
tissues, leading to fibrosis. The first discovery was in 
2001  1, when the sclerosing autoimmune pancreatic 
disease was associated to extra pancreatic sites. The 
most frequently involved sites include bile ducts and 
gallbladder, liver, salivary glands, and kidneys, gener-
ally mimicking a neoplasia. The cardinal features are 
histological IgG4 expressing cells, organs fibrosis and 
potential elevation of serum IgG4 2-4. Interestingly, the 
mean age at diagnosis is approximately 60 years, with 
men prevalence (8:3); it indicates an epidemiologic 
trend in older adults  5. The disease pathogenesis re-
mains largely unclear; so far, there is increasing evi-
dence of a Th2-driven immune response, that induces 
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IgG4 production, associated to innate immunity activa-
tion (toll-like receptors and monocytes and basophiles) 
and potentially mediated by infectious agents. 
The diagnosis may be challenging when unusual or-
gans are involved or pre-existing comorbidity is present, 
delaying the early therapeutic interventions. The under 
diagnosis is particularly frequent in elderly subjects, due 
to the co-occurrence of multimorbidity, polypharmacy 
and clinical complexity. 
We reported a clinical case of IgG4-related systemic 
disease in an oldest old woman. The clinical case is 
original and outlined the difficulty in the diagnostic 
workout of this elderly autoimmune disease due to the 
oldest old patient’s clinical phenotype.
case report
An old woman of 85 years was admitted to our geriatric 
ward (IRCCS University Hospital, San Martino Genoa, 
Italy) for remittent fever and functional decline. Her clini-
cal history included arterial hypertension, osteoporosis 
and a polypharmacy (ramipril 5  mg oad, alendronate 
70  mg oaw, calcium/Vit. D  oral supplementation of 
1000 mg/800 UI oad and prednisone 5 mg oad). The 
steroid therapy was introduced in 2009 when the pa-
tient had suffered from an abdominal colic; a previous 
CT scan described a storiform fibrous mass, suggestive 
of retroperitoneal fibrosis of unknown origin.
At the time of in hospital admission, patient’s clinical 
examination was non informative, other than a mild low 
abdomen tenderness. Laboratory tests, showed a mild 
increase of inflammatory plasmatic markers (erythrocyte 
sedimentation rate, ERS 30 mm/h; C-reactive protein, 
CPR 10 mg/l).
The comprehensive geriatric assessment showed a 
functional decline (ADL 3/6, IADL 3/8), a malnutrition 
risk (MNA 17/30), a mild cognitive impairment (MMSE 
25/30) and a moderate comorbidity status (CIRS 4/13).
The chest X-ray showed an upper mediastinum enlarge-
ment; a thorax-abdomen contrast enhanced CT and 
PET- CT scans showed periaortic inflammatory fibrosis, 
the aneurysm of the descendent aorta (max AP diameter 
55 X44 mm) and of the anonym artery (max AP diameter 
23 mm). A hydronephrosis, due to retroperitoneal fibrosis, 
that encapsulated the ureter was also observed (Fig. 1-2). 
The differential diagnosis was then formulated. The pa-
tient did not show any clinical sign suggestive of either 
polymyalgia rheumatica or Horton’s aortitis: muscles 
and shoulders did not show any sign of stiffness or 
pain. The patient did not suffer from headache, vision 
difficulties, jaw pain, scalp tenderness and /or temporal 
artery tenderness or decreased pulsation, suggestive of 
gigantocellular aortitis. 
No medium vessel vasculitis sign was demonstrated, 
including myalgias, erythema or maculopapular rush.
Moreover, no small vessel vasculitis sign was observed, 
including polyneuropathy, migratory or transient pulmo-
nary opacities, purpura or organs bleeding. Sarcoidosis 
was also ruled out due to the absence of large lymph 
Figures 1-2: TC and PET-TAC scans showed periaortic inflammatory fibrosis, the aneurysm of the descendent aort (max AP diame-
ter 55 X 44 mm) and of the anonym artery (max AP diameter 23 mm) and hydronephrosis due to retroperitoneal fibrosis.
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nodes involvement, arthritis, rash or erythema nodosum 
and interstitial and fibrotic pulmonary disease. Systemic 
amyloidosis was excluded due to the absence of ne-
phrotic syndrome, autonomic neuropathy with orthostatic 
hypotension. Additionally, anti-nuclear antibody, (ANA); 
anti-neutrophil cytoplasmic antibodies, (ANCA); extracta-
ble Nuclear Antigen Antibodies, (ENA); rheumatoid factor 
(RA test); angiotensin converting enzyme (ACE) resulted 
negative, excluding the autoimmunity hypothesis.
A serum infective panel including Syphilis test, viral, bac-
terial biological samples, micotic (1-3)-β-D-glucan and 
galactomannan blood test ruled out the infective/mycotic 
origin for the aneurysm. Specifically, the patients did not 
show any sign of bacteraemia and/or sepsis to support 
an adjacent aortic spreading from the infectious focus. 
An echocardiography ruled out the presence of infective 
endocarditis. No iatrogenic trauma or prosthetic arterial 
device was present to support a specific risk factor for 
mycotic aneurisms. No immunosuppression state was 
shown counting for opportunistic infections. The clinical 
hypothesis of neoplasia and or lymphoma was also clini-
cally excluded. Any patient’s drug associated with higher 
risk of retroperitoneal fibrosis was ruled out.
The clinical hypothesis of an IgG4 related systemic dis-
ease was formulated. 
Serum levels of IgG4 were 135 mg/dl (reference values: 
8-135 mg/dl) in spite of a long-term treatment with glu-
cocorticoids 6-7, that is known to blunt the IgG4 medi-
ated response. 
The patient fulfilled most of the current diagnostic crite-
ria for IgG4-RSD, including a clinical presentation with 
fibrous, storiform masses, the plasmatic detection of 
IgG4 ³ 135 mg/dl and the hystopathological mass plas-
macellular infiltration 4.
The patient’s old age did not allow the performing of 
histology, for an unfavourable clinical benefit to risk 
ratio; in keeping with that, the diagnosis of a possible 
IgG4 – related disease was formulated. 
In particular, among the wide spectrum of IgG4 dis-
ease presentation, a IgG4-chronic periaortitis diagnosis 
was formulated for the presence of all the three major 
components: a retroperitoneal fibrosis, IgG4 related ab-
dominal aortitis and peryaneurysmal fibrosis. 
Herein, the patient had an in hospital occurrence of 
Clostridium difficilis colitis, which precluded the admin-
istration of immunosuppressants and the steroid ther-
apy (prednisone 7.5 mg oad) was increased to provide 
the optimal therapeutic effect.
dIscussIon
The present clinical case is original and adds knowl-
edge to the 76 cases of thoracic aortitis due to IgG4 
systemic disease out of the 3482 cases of disease re-
ported so far 5 8.
IgG4-RD is not a truly new disease, as many single clin-
ical conditions (e.g., Mikulicz disease, Kuttner tumour, 
Riedel thyroditis, Ormond’s disease), once considered 
as separate clinical entity, are now included under its 
clinical wide spectrum 9 10. 
So far, IgG4 is a multisystem disorder with a mean of 
2 organ involvement; the hepato pancreaticobiliary sys-
tem is the most commonly involved apparatus, followed 
by the parotid salivary glands anatomical system 11.
Interestingly, accumulating evidence indicates that in 
nearly half the cases, retroperitoneal fibrosis may be 
among the first clinical manifestation of IgG4-RD  9, 
partially overturning the rareness of the retroperitoneal 
fibrosis in the idiopathic form.
Male and female differed in their organ representation; 
male predominantly presented with periaortitis while 
women presented with sialodacryoadenitis  12, even if 
the reasons for differential organ expression in the two 
sexes is still unclear. 
With regard to that, the present clinical case is original, 
referring to the IgG4 clinical presentation with chronic 
periaortitis in an oldest old woman.
In particular, the Ormond’s disease, once recognized 
as isolated idiopathic disorder, is now classified within 
the disease grouping known as chronic periaortitis, 
including aortic abdominal aortitis and peryaneurismal 
fibrosis.
The presentation of IgG4 chronic periaortitis can be as-
pecific and subtle as in the reported clinical case. Com-
mon symptoms are pain in the back, lower abdomen, 
hydroneprhosis from ureteral involvement and storiform 
fibrosis of retroperitoneum, especially for long standing 
cases. 
The diagnosis of chronic IgG4 aortitis was formulated 
with a level of possibility due to the lack of biopsy.
However, it is also important to note that even if the 
tissue biopsy is the gold standard for the diagnosis of 
IgG4 RS, there is increasing indication to supporting 
clinic pathological evidence to confirm the diagnosis. 
This statement is of key relevance when dealing with 
older and frail elderly subjects where a biopsy proce-
dure may be of difficult performance. 
Corticosteroids represent the first line treatment, but 
the conventional steroid sparing agents (azathioprine, 
mycophenolate mofetil and methotrexate) may achieve 
additional immunosuppression benefit, lacking pro-
spective controlled studies to test their efficacy. The 
caveats to such therapeutic immunosuppressive inter-
ventions pose additional concerns when dealing with 
an oldest old and comorbid patient.
In this clinical case, low dose chronic steroids were initi-
ated in 2009, inducing a clinical remission; it is known 
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that, low steroid dose treatment at initial treatment and 
low levels of serum IgG4 in cases with organ dysfunc-
tions are associated to disease recurrence, as occurred 
in the clinical report 13. 
The IgG4 RS represents a challenge in geriatrics, even 
if the disease nomenclature has been standardized, 
consensus have been reached and effective treatments 
have been identified.
In particular, the epidemiology of the disease in the 
older adult population is largely unknown, because of 
the challenges in early recognition and treatment. 
The disease multi organ involvement and storiform 
fibrotic masses presentation often arises concern for 
malignancies or may be underdiagnosed in elderly, due 
to the co-occurrence of multimorbidity and disease 
smouldering courses. For instance, many elderly pa-
tients, with elevated plasmatic creatinine and urea lev-
els, associated to gastritis, chronic thyroditis, recurrent 
cholangitis and chronic pancreatitis are erroneously 
attributed to multimorbidity and treated for the single 
organ clinical condition. Additionally, the presence of 
organ mass involvement, may be erroneously suspect-
ed of malignancy, initiating a patient’s distressing and 
inconclusive oncological diagnostic workout.
From a pathogenetic view point, the ageing process is 
characterized by the immunosenescence 14, that may 
boosts autoimmunity; the enhanced reactivity to self-
antigens and the loss of tolerance, explaining both the 
general inflammation (inflammaging)  15 and the rise of 
autoantibody (altered T- and B-cell functions, especially 
to the decrease in antibody affinity maturation) may 
constitute the pathogenetic background for it 5. In ad-
dition, epigenetic changes associated to aging (DNA 
methylation, histone modifications, telomeres shorten-
ing) may also contribute to foster late onset autoim-
mune diseases in elderly.
IgG4-RD is a clinical issue of growing interest: to date, 
indeed, few studies have reported, analytically, the sys-
temic involvement of the disease in larger cohorts of 
patients 10. 
Anyway, greater understanding of the immunopathol-
ogy of IgG4 diseases and interactions between T cell 
different pathways will be of key relevance in dissecting 
the IgG4 disease pathogenesis. 
Further, greater awareness of IgG4-RD mediated 
pathogenesis is needed, especially in geriatrics, and a 
multidisciplinary collaboration is warranted to provide 
evidence based results and to improve the appropriate-
ness and accuracy of the clinical management of this 
emerging immune mediated disease of the older age. 
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